Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 16Advanced Breast Cancer 2Sarcoma, Endometrial Stromal 1Recurrence 1Perivascular Epithelioid Cell Neoplasms 1Neoplasms by Site 1Neoplasms 1Neoplasm Metastasis 1Endometrial Neoplasms 1ESR1 Gene Mutation 1ER+ Breast Cancer 1Central Nervous System Neoplasms 1Central Nervous System Diseases 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Breast Neoplasms, Male 1Breast Diseases 1Brain Neoplasms 1Brain Diseases 1Adenosarcoma of the uterus 1

Interventions

Tamoxifen 6Specimen Handling 6Anastrozole 3exemestane 2Surveys and Questionnaires 2Radiosurgery 2Letrozole 2Genetic Testing 2Biopsy 2poly ICLC 1elacestrant 1Testosterone 1Standard of Care 1Sentinel Lymph Node Biopsy 1Selective Estrogen Receptor Modulators 1Restraint, Physical 1Radiotherapy 1Practice Guidelines as Topic 1Patient Navigation 1Omacor 1Multicenter Studies as Topic 1Methods 1Meditation 1Medicare 1Mastectomy, Segmental 1Mastectomy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Follow-Up Studies 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Intraductal, Noninfiltrating × elacestrant × Clear all
NCT06075953 2026-05-22

DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment

QuantumLeap Healthcare Collaborative

Phase 2 Recruiting
400 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡